{"id":428766,"title":"Notice: Prescription Drug List (PDL): Multiple additions [2018-11-01] - Canada.ca","sourceCode":"hc","sourceName":"Health Canada","language":"en","captureDate":"2026-01-02","captureTimestamp":"2026-01-02T00:32:50.225000+00:00","jobId":6,"originalUrl":"https://www.canada.ca/en/health-canada/services/drugs-health-products/drug-products/prescription-drug-list/notice-prescription-drug-list-2018-11-01.html","snippet":"Notice: Prescription Drug List (PDL): Multiple additions Date: November 1, 2018 Our file number: 18-116661-578 The purpose of this Notice of Amendment is to notify about the additions of Cabozantinib, Doravirine, Inotersen, Lanadelumab, Patiromer, Telotristat, and Zaleplon to the…","rawSnapshotUrl":"/api/snapshots/raw/428766","browseUrl":"https://replay.healtharchive.ca/job-6/20260102003250/https://www.canada.ca/en/health-canada/services/drugs-health-products/drug-products/prescription-drug-list/notice-prescription-drug-list-2018-11-01.html#ha_snapshot=428766","mimeType":"text/html","statusCode":200,"captureBackend":"browsertrix","captureFidelity":"high"}